8-142912224-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000498.3(CYP11B2):​c.1399-131G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000015 in 1,336,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0.0000015 ( 0 hom. )

Consequence

CYP11B2
NM_000498.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.435

Publications

0 publications found
Variant links:
Genes affected
CYP11B2 (HGNC:2592): (cytochrome P450 family 11 subfamily B member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP11B2NM_000498.3 linkc.1399-131G>C intron_variant Intron 8 of 8 ENST00000323110.2 NP_000489.3 P19099

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP11B2ENST00000323110.2 linkc.1399-131G>C intron_variant Intron 8 of 8 1 NM_000498.3 ENSP00000325822.2 P19099
GMLENST00000522728.5 linkc.182-1739C>G intron_variant Intron 3 of 4 3 ENSP00000430799.1 E5RI31

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
AF:
0.00000150
AC:
2
AN:
1336642
Hom.:
0
AF XY:
0.00000151
AC XY:
1
AN XY:
662486
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30830
American (AMR)
AF:
0.00
AC:
0
AN:
35658
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24590
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35940
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77856
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41068
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4944
European-Non Finnish (NFE)
AF:
0.00000194
AC:
2
AN:
1029610
Other (OTH)
AF:
0.00
AC:
0
AN:
56146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.44
DANN
Benign
0.35
PhyloP100
-0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6433; hg19: chr8-143993640; API